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ABSTRACT 
 




Transport Protein Particle (TRAPP) is a multisubunit tethering complex that is involved in 
membrane trafficking. Lately, there have been numerous cases of proteins with membrane 
trafficking functions that have been found to have separate functions. These moonlighting 
functions occur either in a distinct cellular location or during a different phase of the cell cycle. 
Here we present the unexpected finding that a protein TRAPPC12, a subunit of the mammalian 
TRAPPIII membrane trafficking complex, plays a role in mitosis. Depletion of TRAPPC12 results 
in mitotic arrest of the cells. Our results show that TRAPPC12 is hyperphosphorylated early in 
mitosis and dephosphorylation of TRAPPC12 is necessary for the cell cycle progression. 
Finally, we demonstrate that a phosphomimetic form of TRAPPC12 leads to an increase in 
mean mitotic index than does the non-phosphorylatable mutant. Our study identifies a 
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1.1  The cell cycle 
In 1882, Walther Flemming was one of the first scientists to present a detailed 
description of the events that take place during cell division in animals and named the 
division of somatic cells “mitosis” (Flemming, 1882, see the translation in 1965). He 
originally coined the term “mitosis” from the Greek word for thread, because of the shape 
of mitotic chromosomes. The precision and fidelity of a cell to divide into two daughter 
cells that contain identical genetic material is vital for all forms of life. The event that 
leads to the reproduction of all cells is called the cell cycle. In eukaryotic cells the cycle 
is composed of five distinct phases: G1 (Gap1), S (Synthesis)-phase, G2 (Gap2) 
(collectively referred to as interphase), Mitosis and Cytokinesis (collectively referred to 
as M-phase). Mitosis can be further subdivided into a number of distinct phases that are 
distinguished both morphologically and biochemically. 
 
1.1.1 Interphase 
Cells spend most of their time in interphase where they are metabolically active 
and growing, preparing for cell division. Interphase is divided into three phases: G1 (Gap 
1), where the cell grows and prepares for entry into S (DNA synthesis) phase; S-phase, 
which is characterized by replication of DNA; and G2 (Gap 2) phase which ensures that 
the DNA is correctly replicated before the cell irreversibly enters mitosis (Blow and 
Tanaka, 2005; Nurse, 2001). 
 
1.1.2 Mitosis 
One recognizable feature of a eukaryotic cell is the presence of the nucleus that 
contains the genetic material. After the DNA is duplicated in S phase the cells prepare to 
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enter mitosis where duplicated DNA condenses into chromosomes (organized structures 
of DNA and protein). Chromosomes are composed of two sister chromatids (identical 
copies of a chromosome), each of which will be segregated into a different daughter cell. 
Mitosis can be divided into five progressive phases called prophase, prometaphase, 
metaphase, anaphase and telophase (Moorhead and Hsu, 1956) that work together 
through different checkpoints to ensure the equal distribution of the sister chromatids to 
each daughter cell. Cytokinesis begins at the same time as telophase and often is 
thought of as a part of it, but it is indeed a separate process (Figure 1.1). 
 
In most eukaryotes the nuclear envelope breaks down during prophase. During 
prophase, the paired chromosomes condense and are bound together at the centromere 
by the cohesin complex (Lloyd and Chan, 2006). At this time, key complexes and 
proteins such as the Ndc80 complex, KNL and the Mis12 complex start to bind to the 
kinetochore (a larger structure at the centromeric region of the chromosomes; see below 
section 1.4) preparing for spindle microtubule attachment. This is followed by 
prometaphase where microtubules elongate from centrosomes capturing the newly 
replicated chromosomes which then congress to the metaphase plate (Kotwaliwale and 
Biggins, 2006) where they align during metaphase (Maiato et al., 2004). Anaphase 
begins with the separation of sister chromatids that start moving to opposite poles of the 
cell due to shortening of kinetochore microtubules. Afterward, the polar microtubules 
elongate and the two poles of the spindle move farther apart. The nuclear envelope 
starts to reform around the decondensed chromosomes and metabolic activity is 
restored during telophase. The separation of cytoplasm and the formation of the 
cleavage furrow ingression occurs during cytokinesis, leading to the formation of two 






Figure 1.1. An overview of Mitosis. During early mitosis, the pairs of sister chromatids 
are attached to the mitotic spindle by microtubules. By mid-mitosis or metaphase, each 
of the pair of sister chromatids are attached to separate microtubules, originating from 
opposite poles of the spindle, with sister chromatid cohesin destroyed during anaphase, 
whereby microtubules pull the separated chromosomes to opposite ends of the cell. The 
two sets of chromosomes are packaged into two daughter nuclei, with constriction of the 
cytoplasm and deposition of a new membrane during telophase/cytokinesis marking the 





1.2  Mitotic kinases  
Phosphorylation is a major posttranslational modification of proteins involved in 
many stages of the cell cycle, especially during mitosis. Protein phosphorylation is 
mediated by kinases, some of which are critical to the progression of mitosis. The most 
crucial kinases involved in mitosis will be discussed in the sections below. 
 
1.2.1 Cyclin-dependent kinases  
Cyclin-dependent kinases (CDKs), a family of multifunctional enzymes, are 
among the main factors that drive cell cycle progression in mammalian cells (Morgan, 
2010; Murray, 2004). The enzymatic activity of CDKs varies with expression levels of the 
cyclins that bind to CDKs and activate them. The formation of cyclin-CDK complexes 
drives the cell cycle by phosphorylating substrates and changing their enzymatic activity 
or their interaction with other proteins. The amount of CDKs remains constant during the 
cell cycle compared to the varying levels of cyclins (Arellano and Moreno, 1997). The 
production and degradation of specific cyclins during various phases of the cell cycle is 
what drives the cell cycle from one phase to another, and these cyclins can be used as 
biochemical markers for stages of the cell cycle. Failure to degrade specific cyclins 
results in the arrest of the cell cycle (Fisher et al., 2012). In the beginning of G1, 
expression of cyclin D activates CDK4 and CDK6, and cyclin E binds to CDK2 (Shapiro, 
2006). During S phase cyclin A activates CDK2 and has an important role in DNA 
replication (De Boer et al., 2008). In early G2 phase, cyclin A associates with CDK1 
driving the progression of the cell through G2 phase (De Boer et al., 2008; DeGregori 
and Johnson, 2006; van den Heuvel and Dyson, 2008; Vigo et al., 1999). Cyclin B 
complexed with CDK1 is the primary CDK complex required for mitotic progression 
(Arellano and Moreno, 1997). The levels of cyclin B start increasing during G2 phase 
when it binds to CDK1 but the complex is kept inactive at this stage by phosphorylation 
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of the T14 and Y15 residues of CDK1 by the Wee and Myt kinases (Mueller et al., 1995; 
Parker and Piwnica-Worms, 1992) and is activated in prophase by dephosphorylation of 
these sites mediated by Cdc25 phosphatase (Boutros et al., 2006). While cyclin B-CDK1 
is mainly activated within the nucleus, cyclin B contains a nuclear export signal (Moore 
et al., 1999) which localizes it to the cytoplasm until the beginning of prophase (Porter 
and Donoghue, 2003). Therefore, the initial activation of cyclin B-CDK1 occurs in the 
cytoplasm, which controls the timing of its activation in the nucleus. Cyclin B-CDK1 is 
imported into the nucleus just before nuclear envelope breakdown (NEBD) (Gavet and 
Pines, 2010; Peter et al., 1991). The cyclin B-CDK1 complex is known to phosphorylate 
a number of substrates during mitosis and, thus, it is involved in different functions such 
as chromosome condensation, centrosome separation, and assembly of the mitotic 
spindle (Blangy et al., 1995; Kimura, Hirano, Kobayashi and Hirano, 1998). It is also 
involved in the regulation of the anaphase- promoting complex/cyclosome (APC/C) 
(Sudakin et al., 1995; Zachariae et al., 1998).  
 
1.2.2 Polo-like kinases  
Polo-like kinases (PLKs) also have an essential role in the progression of the cell 
cycle. All PLKs have an N-terminal serine/threonine kinase domain, a highly conserved 
C-terminal polo-box domain (PBD) and are activated by phosphorylation of a region 
called the T-loop (Mundt et al., 1997). It has been shown that PLKs cooperate with 
CDKs to regulate the cell cycle through an involvement in the activation of cyclin B-
CDK1 during mitotic entry (Toyoshima-Morimoto at al., 2002; Watanabe et al., 2004). 
Plk1 is a member of the PLK family that is highly expressed during mitosis (Barr et al., 
2004). The activity of Plk1 is regulated by phosphorylation (Barr et al., 2004) and protein 
degradation (Lindon and Pines, 2004). During mitosis, Plk1 is located in various 
subcellular structures including centrosomes, kinetochores, the central spindle and the 
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midbody, demonstrating the critical role that this kinase has in the orchestration of cell 
division (Arnaud at al., 1998; Golsteyn et al., 1995; Petronczki et al., 2008). 
 
1.2.3 Aurora kinases 
Aurora kinases have been found to play an essential role in different mitotic 
events. The Aurora family components are serine/threonine kinases that regulate 
essential processes from mitotic entry to cytokinesis (Dutertre et al. 2002). In mammals, 
three members of the Aurora kinase family are known: Aurora A, B and C. Aurora A is 
mainly involved in centrosome maturation and the separation of the duplicated 
centrosomes (Terada et al. 2003; Mori et al. 2007; Glover et al. 1995; Liu and Ruderman 
2006). Aurora A kinase involvement is also required for the activation of  Cdc25B at the 
centrosomes that leads to initial cyclin B-CDK1 activation at the centrosomes during the 
G2/M transition (Cazales et al. 2005, Lindqvist et al. 2005, Seki et al. 2008).  
Aurora B has a broader function in mitotic events and is the catalytically active member 
of the chromosomal passenger complex (CPC), a central regulator of mitotic progression 
(Ditchfield et al., 2003; Hauf et al., 2003). An essential role of Aurora B is the correction 
of kinetochore-microtubule attachment by phosphorylating key substrates at the 
kinetochore (see below, section 1.4) such as CENP-A and the chromosome passenger 
complex (CPC) subunits survivin, borealin and inner centromere protein (INCENP). 
Aurora B promotes the destabilization of abnormal chromosome attachments and 
kinetochore-microtubule turnover in merotelic (a single kinetochore is attached to 
microtubules emanating from both spindle poles) attachments (Lampson et al., 2004, 
Cimini et al., 2006). This leads to an “indirect” role in the activation of the spindle 
assembly checkpoint (SAC, see section 1.3.2) that results in the inhibition of the 
anaphase-promoting complex (APC/C). Aurora B also senses the tension at the 
kinetochore-centromere region leading to SAC activation in response to the absence of 
 7	  
tension (Cimini, 2007; Musacchio and Salmon, 2007). In contrast, little is known about 
Aurora C but it has been shown that its function overlap and is able to compensate for 
the loss of Aurora B. This may be due to sequence homology between Aurora B and C 
in the central catalytic kinase domains (Nigg, 2001; Sasai et al., 2004). 
 
1.3 Cell cycle checkpoints 
Checkpoints are control mechanisms that monitor the cell cycle, effectively 
arresting cell cycle progression at various steps until previous events has been 
successfully completed. The central components of the cell cycle control are cyclin-
dependent kinases (CDKs) (see section 1.2.1). Errors during cell division might lead to 
serious diseases such as cancer, cardiovascular disease, autoimmune and metabolic 
disorders, viral infections, atherosclerosis and premature aging (Bicknell and Brooks, 
2008; Foster, 2008; Zhivotovsky and Orrenius, 2010). In order to avoid cell division 
errors, the cell verifies that proper conditions are satisfied at crucial steps in the division 
process. In general, cell cycle progression is governed by three major checkpoints: G1/S 
checkpoint, G2/M checkpoint and the mitotic Spindle Assembly Checkpoint (SAC). 
 
1.3.1 G1 and G2 Checkpoints 
The presence of DNA damage is a common factor that triggers the activation of 
both G1 and G2 checkpoints. There are different types of DNA damage that lead to 
checkpoint arrest. For example the damage that results in single stranded breaks 
caused by external stimuli activates the ATR dependent pathways and other damages 
that result in double stranded breaks activate the ATM protein kinase activity (Chan et 
al., 2000). 	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 The G1/S checkpoint occurs during G1 phase, and it monitors nutritional status, 
cell size, DNA/cellular damage and growth factor availability. If this checkpoint is 
activated in G1, it will delay the onset of S-phase and DNA replication (Stein et al., 
2012). The G1/S checkpoint is dependent upon the tumour suppressor gene, p53, which 
protects cells from becoming tumorigenic (Vogelstein et al., 2000). ATM and ATR are 
involved in sensing DNA damage and can activate p53 via phosphorylation during the 
G1/S checkpoint (el-Deiry et al., 1993). 
 
The G2/M checkpoint occurs during G2-phase, and it monitors the completion of 
DNA replication, assuring correct transmission of genetic material (Stein et al., 
2012).The G2 phase DNA damage checkpoint has both p53 dependent and 
independent mechanisms (Chang and Eastman, 2012; Taylor and Stark, 2001). The 
p53-dependent arrest activates a long term arrest (days), whereas p53-independent 
mechanisms initiate an immediate arrest that can be stable for a matter of hours (Bunz 
et al., 1998). Both mechanisms target the regulation of the cyclin B-CDK1 complex, 
required for M phase progression, however the mechanisms by which these are 
imposed are different.  
 
p53-independent mechanisms involve the kinases, ATR/ATM, which through 
their downstream targets and subsequent phosphorylation cascades lead to cyclin B-
CDK1 inactivation. ATM/ATR initiates a more rapid checkpoint response to DNA 
damage than p53, however if a prolonged arrest is required p53 dependent pathways 
will predominate. This may be facilitated by ATM phosphorylation of the p53 inhibitor, 
MDM2, as well as ATM/ATR phosphorylation of p53 itself on Ser15 to increase p53 
stability (Canman et al., 1998; Khosravi et al., 1999; Maya et al., 2001; Tibbetts et al., 
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1999). Therefore the pathways activated during the G2 checkpoint are dependent on the 
extent of damage. 
 
1.3.2 The Spindle Assembly Checkpoint  
The spindle assembly checkpoint (SAC) is an important mitotic control that 
ensures equal chromosome segregation by suspending division until all chromosomes 
are oriented correctly at the mitotic spindle. The core SAC proteins (Minshull et al., 
1994) include the MAD proteins Mad1, Mad2, and Mad3 (BubR1 in humans) (Li and 
Murray, 1991) and the BUB proteins Bub1 and Bub3 (Hoyt et al., 1991), all of which are 
conserved among eukaryotes. 
 
The proper segregation of chromosomes during anaphase is a crucial step of 
mitosis. The SAC guards the fidelity of chromosome segregation by preventing the cell 
from entering anaphase until all chromosomes are attached to the spindle apparatus in a 
bipolar (sister kinetochores are attach to microtubules extending from opposite spindle 
poles) manner and that the proper tension is applied across the sister centromeres 
(Musacchio and Salmon, 2007). Incorrect chromosome segregation may lead to cell 
death (Weaver and Cleveland, 2005) or generate aneuploidy (Kim and Kao, 2005; 
Steuerwald, 2005), a condition where there are unequal numbers of chromosomes in the 
daughter cells. The SAC delays anaphase in the presence of unattached or incorrectly 
attached kinetochores by preventing the activation of the anaphase-promoting complex 
(APC/C). The anaphase-promoting complex (APC) contains a ubiquitin ligase also 
known as the cyclosome and it is activated by a cofactor called Cdc20. The SAC 
negatively regulates Cdc20 which in turn inhibits the activation of APC-mediated 
polyubiquitylation of two key substrates: Cyclin B1 and securin (Glotzer et al. 1991). By 









Figure 1.2. Principles of the mitotic SAC. Unattached kinetochores catalyze formation 
of the mitotic checkpoint complex (MCC) composed of BubR1, Mad2, Cdc20 and Bub3, 
which block the APC/C. Once all the chromosomes are aligned with their kinetochores 
attached to the spindle (metaphase), the MCC disassembles, releasing Cdc20, a 
cofactor of APC/C. Activated APC/C ubiquitylates its substrates, securin and Cyclin B1, 
which are degraded by the proteasome leading to release of separase and Cdk1. 
Separase cleaves cohesin allowing sister chromatids to separate, which marks the onset 
of anaphase. Image taken from: http://www.le.ac.uk/ge/genie/vgec/he/cellcycle.html  
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Polyubiquitylation of securin is important for full activation of an enzyme called 
separase that specifically cleaves the cohesion complex that holds the sister chromatids 
together. (Figure 1.2) (Nasmyth, 2001). 
 
The mechanism of the inhibition of APC/C by the SAC is still unclear. It may be 
due to the binding of Cdc20 to SAC components or due to the fast turnover of SAC 
components at unattached kinetochores (Musacchio and Salmon, 2007). Several studies 
have proposed a “two step” model for activation and maintenance of the SAC. The first 
is the kinetochore-independent step where the APC/C is inhibited by the production of 
the mitotic checkpoint complex (MCC), a cytosolic multisubunit complex composed of 
Mad2, BubR1 and Bub3, and also by the APC/C regulator Cdc20. The MCC is found to 
be present and active in interphase cells so its inhibition of APC/C activity starts early in 
mitosis, before kinetochore assembly. 
 
The second step is kinetochore-dependent and starts in prophase where SAC 
proteins accumulate at unattached or incorrectly attached kinetochores, and Cdc20 is 
seized by Mad2 and BubR1 (Ciliberto and Shah, 2009; Musacchio and Salmon, 2007). 
When all kinetochores are correctly attached and aligned at the metaphase plate and 
under tension, Cdc20 dissociates from the complex (Mad2-Cdc20 and Bub3-BubR1-
Cdc20) and activates the APC/C. In turn, activation of APC/C mediates degradation of 
both cyclin B1 and securin, and eventual mitotic exit. 
 
1.4 Kinetochores 
Accurate chromosome segregation is achieved when all of the chromosomes are 
oriented correctly at the metaphase plate. Kinetochores are specialized macromolecular 
protein structures that aid in chromosome movement to the metaphase plate. 
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Kinetochores assemble at the centromere of each sister chromatid and interact with 
spindle microtubules during mitosis (Maiato et al., 2004). This interaction creates a 
tension on the bioriented kinetochores that is caused by the pulling force of spindles on 
kinetochore microtubules countering the cohesion of the sister chromatids. In the past 
few years there has been an exponential increase in the identification and understanding 
of the proteins localized at the kinetochore, although more is left to be discovered 
(Cheeseman and Desai 2008; Chan et al. 2005; Santaguida and Musacchio 2009). 
Genomic and proteomic studies have revealed that the kinetochore may exceed 200 
proteins (Ohta et al., 2010; Tipton et al., 2012). In mammalian cells kinetochores are 
divided into two layers called the inner and outer kinetochore. The inner kinetochore is 
located adjacent to the centromere and contains approximately 100 proteins including 
the histone H3 variant CENP-A (Fachinetti et al., 2013). The outer kinetochore contains 
roughly 20 known proteins that assemble adjacent to the inner kinetochore after nuclear 
envelope breakdown (NEBD). Most of the known microtubule interacting proteins like 
CENP-E, dynein and checkpoint proteins are part of the outer kinetochore (Cooke et al., 
1997a). The outer kinetochore proteins are divided into subgroups that localize to the 
kinetochore at different points of mitotic progression and their localization was 
determined based on many experiments and assays throughout the years (Cheeseman 
et al.i, 2006; Cheeseman et al., 2008; Foltz et al., 2006; Liu et al., 2006; Maiato et al., 
2004; Musacchio and Salmon, 2007). Three important complexes of the outer layer of 
the kinetochore are the Mis12 complex, Knl1 and the Ndc80 complex (collectively 
referred to as the KMN network) which serve as a scaffold for SAC proteins but are also 
key regulators of microtubule attachment (Cheeseman et al., 2006). The association of 
the KMN network with kinetochores begins in prophase and ends in telophase 
(Santaguida and Musacchio, 2009). The Ndc80 complex consists of four members 
including Ndc80, (Hec1 in humans), Nuf2, Spc24 and Spc25, and it is essential for 
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kinetochore-microtubule attachments (DeLuca et al., 2002; McCleland et al., 2003).  The 
Mis12 complex is composed of Nnf1, Mis12, Dsn1 and Nsl1 and it serves as a major 
platform for outer kinetochore assembly (Cheeseman and Desai, 2008). Knl1 (also 
referred as CASC5 or blinkin in humans) is recruited to the kinetochore by Mis12 
complex and it has been shown to have a role in the recruitment of other outer 
kinetochore proteins such as ZWINT and CENP-F, and SAC proteins such as BUB1 and 
BUBR1 (Cheeseman et al., 2008). The microtubule binding affinity of the kinetochores is 
increased when the Ndc80 complex associates with Knl1 and Mis12 complex 
(Cheeseman et al., 2006). Preventing one of the KMN members from localizing to the 
kinetochore results in chromosome segregation defects and either a partial or complete 
detachment of the kinetochore from the microtubules (Cheeseman et al., 2008; DeLuca 
et al., 2005; Kline et al., 2006). Phosphorylation of KMN proteins by Aurora B kinase 
decreases their affinity for microtubules. When the microtubule is properly attached to 
the kinetochore, the increased tension pulls the KMN network further away from Aurora 
B, thereby decreasing the ability of Aurora B to phosphorylate the KMN network. In the 
case of incorrectly attached microtubules, the KMN network cannot be pulled away from 
Aurora B. Keeping the KMN network phosphorylated leads to destabilized microtubule-
kinetochore attachments that allow the microtubule to detach and try again.(Cheeseman 
et al., 2006). 
 
Assembly of the kinetochore onto centromeric DNA is mediated by the modified 
histone H3 variant called CENP-A that is part of the inner kinetochore. CENP-A is part of 
a network of 16 peripheral centromeric proteins including CENP-C, -H, -I, -K, -L, -M, -N, -
O, -P, -Q, -S, -T, -U, -W and –X that is collectively referred to as the constitutive 
centromere-associated network (CCAN) (Foltz et al., 2006; Hori et al., 2008; Okada et 
al., 2006). The main function of the CCAN is to link the centromeric DNA on the inner 
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kinetochore with the microtubule-bound KMN network of the outer kinetochore (Hori et 
al., 2008; see review by Varma and Salmon, 2012). 
 
Spindle microtubules that attach to kinetochores are called kinetochore 
microtubules. Kinetochores have multiple sites where the microtubules attach by the 
plus end and as the microtubules shrink the kinetochore (and the chromosome) moves 
towards the spindle pole where the minus end of the microtubule is attached (Wittmann 
et al., 2001). 
 
1.5 Motor proteins 
Motor proteins use the energy from ATP hydrolysis to regulate microtubule 
dynamics, help to perform microtubule sliding, move chromosomes along microtubules 
or pull microtubules toward the cell poles (Zhu et al., 2005). One of the major driving 
forces of spindle bipolarity is the microtubule sliding and it is mainly carried out by the 
plus end-directed kinesin-5 Eg5/KIF11 (Blangy et al., 1995; Zhu et al., 2005). Another 
motor protein is the centromere-associated motor protein CENP-E. CENP-E is 
implicated in chromosome positioning, it is important for chromosome congression and 
helps align chromosomes towards the metaphase plate (Cooke et al., 1997a; Kapoor et 
al., 2006; Schaar et al., 1997; Yen et al., 1991).The essential roles of motor proteins 
during mitotic spindle assembly make them good molecular targets for anticancer 
therapy and currently inhibitors of Eg5 and CENP-E are being tested in clinical trials 
(Rath and Kozielski, 2012). 	  
1.5.1 CENP-E 
CENP-E was first discovered in human cells with a monoclonal antibody against 
human mitotic chromosome scaffold proteins. It was later found to belong to the kinesin 
 15	  
family of motor proteins (Kinesin 7) and localized at the kinetochore (Yen et al., 
1991;Yen et al., 1992). CENP-E is a large protein (312 kDa in human) with a kinesin 
motor domain at the N-terminal that activates BubR1 kinase activity (Mao et al., 2003). 
The expression of CENP-E is regulated in a cell cycle-dependent manner that is 
consistent with its function during mitosis (Weaver et al., 2003). CENP-E is recruited at 
the kinetochore shortly after NEBD and it localizes to the outer kinetochore from early 
prometaphase through metaphase. During late anaphase and telophase it moves to the 
spindle midbody after which it starts to gradually degrade (Cooke et al., 1997b; Yao et 
al., 1997; Brown et al., 1996). Initially, CENP-E was reported to be a minus end-directed 
motor (Thrower et al., 1995) but later Wood and co-workers showed the recombinant 
motor domain to move toward the microtubule plus-end in vitro (Wood et al. 1997). 
 
1.5.1.1 Role of CENP-E in the microtubule capture at kinetochores 
Studies have shown that interfering with CENP-E function results in one or a few 
misaligned chromosomes (Putkey et al., 2002; Mcewen et al., 2001; Yao et al., 2000). 
CENP-E is responsible for the stable capture of kinetochores by spindle microtubules 
and is essential for congression of initially unaligned chromosomes (Yen et al., 1991; 
Kapoor et al., 2006; Schaar et al., 1997). Altering CENP-E function by using antibody 
injection (Schaar et al., 1997), depletion (Wood et al. 1997, Yao et al., 2000), gene 
inactivation (Putkey et al., 2002), or inhibition with a small-molecule inhibitor (Wood et 
al., 2010) blocks microtubule plus-end-directed motion of pole-proximal chromosomes, 
which is followed by a failure of kinetochores to form stable microtubule attachments. 
The general assumption that chromosome congression requires all chromosomes to be 
bioriented before congression was challenged in 2006 by Kapoor and colleagues where 
they showed that chromosomes can congress to the metaphase plate before 
biorientation through a mechanism that is dependent upon CENP-E (Kapoor et al., 
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2006). In the CENP-E- dependent mechanism, the monooriented chromosome (a 
chromosome attached only at one of the kinetochores by spindle microtubules) is able to 
congress to the metaphase plate by using kinetochore fibers of the already bioriented 
chromosomes. This way, CENP-E plays an important role in transporting the 
monooriented chromosomes from the spindle pole to the spindle plate where they can 
find connections from the opposite pole and become bioriented (Kapoor et al., 2006). 
 
1.5.1.2 Role of CENP-E in the spindle assembly checkpoint  
In addition to its role in kinetochore-microtubule capture, CENP-E has been 
reported to have a role in the spindle assembly checkpoint. CENP-E’s role in the SAC is 
best described as the binding partner of the checkpoint kinase BubR1 (Chan et al. 1999; 
Mao et al., 2003b; Yao et al., 2000). Among other proteins of the SAC, CENP-E and 
BubR1 are two important proteins of the outer kinetochore. BubR1 has a role in 
kinetochore-microtubule attachment and metaphase chromosome alignment in 
mammalian cells and in vitro assays of recombinant CENP-E and BubR1 have shown 
that CENP-E greatly enhances the activity of BubR1 toward itself (Lampson and Kapoor, 
2005; Mao et al., 2003b; Weaver et al., 2003). Kinase activity of BubR1 is active in 
mitotic cells and it is important for its checkpoint function by monitoring CENP-E-
dependent activities at the kinetochore and regulating APC/C activity (Chan et al., 1999). 
In the presence of one or few unattached kinetochores, CENP-E recruits BubR1 to the 
polar kinetochores leading to the activation of the SAC (Weaver et al., 2003). The 
checkpoint activity of BubR1 is regulated by conformational changes in CENP-E when it 
interacts with microtubules, thus implicating CENP-E in the activation and maintenance 
of mitotic checkpoint signaling (Abrieu et al., 2000). Upon capture of the microtubules, 
CENP-E silences the BubR1 kinase activity by forming a ternary complex of BubR1-
CENP-E-microtubule (Mao et al., 2005). BubR1 in the ternary complex is unable to 
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associate with Cdc20, which in turn can be free to activate the APC/C complex (see 
section 1.3.2) ( Mao et al., 2003b).  Compared with the depletion of Mad2 or BubR1 in 
human cells, the depletion of CENP-E does not speed up mitosis (Meraldi et al., 2004). 
Instead it leads to a long term mitotic arrest caused by one or more misaligned 
chromosomes, indicating that the checkpoint is functional in humans in the absence of 
CENP-E (Yao et al., 2000). A weak checkpoint does not result in cell death, and 
interference with essential checkpoint genes in mice was shown to lead to an increase in 
aneuploidy (Weaver and Cleveland, 2005; Weaver et al., 2003). 
 
1.6 TRAPP complex 
Proliferating cells must harmonize their growth and division so that cells divide 
when they have grown sufficiently. Mitosis and membrane trafficking are among most 
essential processes in eukaryotic cells. Membrane trafficking allows for cells to maintain 
cellular homeostasis by delivering new materials to the plasma membrane via the 
secretory pathway. In the secretory pathway, vesicle-mediated transport between 
organelles ensures specificity in protein localization. Transport protein particle (TRAPP) 
is a multisubunit tethering factor that is evolutionarily conserved. Initially, TRAPP was 
described as a large protein complex that functions in endoplasmic reticulum (ER)-to-
Golgi traffic in yeast (Sacher et al., 1998; Sacher et al., 2000). Later, more distinct forms 
of TRAPP with specific functions were identified. To date, there are three known TRAPP 
complexes in the budding yeast Saccharomyces cerevisiae that function in ER-to-Golgi 
traffic (TRAPP I) (Sacher et al., 1998), post-Golgi trafficking (TRAPP II) (Sacher et al., 
2001) and autophagy (TRAPP III) (Lynch-Day et al., 2010). In contrast, in mammalians 
only TRAPP II and III have been observed (Bassik et al., 2013). The mammalian TRAPP 
complex contains homologues of all yeast TRAPP subunits named from TRAPPC1 to 





 	   Mammalian	  TRAPP	  subunits	   Accession	  numbers	   	  Complex	  (kDa)	   	  	   	  TRAPPC1	  (17)	   NP_001160093.1	   II,	  III	  TRAPPC2L	  (16)	   NP_057293.1	   II,	  III	  TRAPPC2	  (16)	   NP_001122307.2	   II,	  III	  TRAPPC3	  (20)	   NP_001257824.1	   II,	  III	  TRAPPC4	  (24)	   NP_057230.1	   II,	  III	  TRAPPC5	  (21)	   NP_001035927.1	  	   II,	  III	  TRAPPC6a	  (19)	   NP_001257822.1	   II,	  III	  TRAPPC6b	  (15)	   NP_001073005.1	   II,	  III	  TRAPPC8	  (161)	   NP_055754.2	   III	  TRAPPC9	  (140)	   NP_001153844.1	   II	  TRAPPC10	  (142)	   NP_003265.3	   II	  TRAPPC11	  (129)	   NP_068761.4	  	   III	  TRAPPC12	  (79)	   NP_057114.5	   III	  TRAPPC13	  (46)	   NP_001087224.1	   III	  
 
Table 1.1 Nomenclature of mammalian TRAPP subunits indicating the complexes in 






TRAPPC13, which have no homologues in S. cerevisiae  (Scrivens et al., 2011; Bassik 
et al., 2013). TRAPPC2 has been shown to be the main adaptor to mediate the 
interaction between both TRAPPC9 and TRAPPC8 (Zong et al., 2012). The fact that 
TRAPPC9 co-purifies with TRAPPC10 but not TRAPPC8 indicates the existence of at 
least two distinct mammalian TRAPP complexes (Zong et al., 2011). This idea was 
reinforced by another study where, based on ricin susceptibility and immunoprecipitation 
studies, it was found that there are two physically distinct complexes: TRAPPII that 
contains the core subunits (C1-C6) plus TRAPPC9 and 10, and TRAPPIII that contains 
the core plus TRAPPC8, 11, 12 and 13  (Table 1.1) (Bassik et al., 2013). Furthermore, 
TRAPPIII as a whole has been suggested to play an important role in human 
papillomavirus (HPV) infection since depletion of TRAPPC8, 11 and 12 was shown to 
facilitate the escape of the HPV genome from the Golgi compartment while the depletion  
of TRAPPC9, a component of mammalian TRAPPII, showed little or no effect (Ishii et al., 
2013). The function of TRAPP as a tethering factor is complemented by its ability to act 
as a guanine nucleotide exchange factor (GEF) for the small GTPase Ypt1/Rab1. All 
three forms of TRAPP have been shown to be GEFs for Ypt1p in yeast and TRAPPII 
may be a GEF for Ypt31p/Ypt32p (Jones et al., 2000; Wang et al., 2000; Chen et al., 
2011; Yamasaki et al., 2009; Lynch-Day et al., 2010). Mammalian TRAPP was shown to 
have GEF activity towards the Ypt1p homologue Rab1 (a small GTPase that regulates 
ER-to-Golgi and early Golgi trafficking) but not the Ypt31p/Ypt32p homologue Rab11 
(Yamasaki et al., 2009). ER-to-Golgi trafficking in mammalian cells differs from yeast 
due to the fusion of COPII vesicles derived from the ER forming the ER-Golgi 
intermediate compartment (ERGIC) (Appenzeller-Herzog and Hauri, 2006). Importantly, 
components of mammalian TRAPP have been localized to the ERGIC and have been 
implicated in ER-Golgi transport (Scrivens et al., 2011; Yu et al., 2006; Zong et al., 
2012).  In addition, depletion of other TRAPP subunits such as TRAPPC11 and 
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TRAPPC12 have been shown to impair both the Golgi and ERGIC, consistent with the 
accepted role of TRAPP in ER-to-Golgi traffic (Choi et al., 2011; Scrivens et al., 2009, 
2011). 
 
Like the yeast TRAPP III complex, mammalian TRAPP III has also been 
implicated in autophagy. A large-scale screen for genes involved in human autophagy 
identified TRAPPC5, 8, 11 and 12 as components of the autophagy machinery 
(Behrends et al., 2010). The research in mammalian TRAPP is still in its infancy but 
steadily progressing, and its importance for better understanding is shown by the 
different roles and functions that the complex as a whole or its individual subunits 
undertake. It is noteworthy that mutations in different TRAPP subunits have been linked 
to a number of diseases (reviewed in Brunet and Sacher, 2014).  
 
1.7 Project: The role of phosphorylated TRAPPC12 during mitosis 
The common method to investigate the role of proteins in the cell is usually done 
by the use of small interference RNA (siRNA). Most of the time knockdowns show a 
particular phenotype, indicating a role of the depleted protein in the cell. Our laboratory 
has been studying the mechanism of membrane trafficking with a particular focus on the 
TRAPP complex. We use siRNA knockdowns extensively to examine the phenotypes of 
individual TRAPP subunits. A general screening of the phenotype resulting from the 
depletion of different TRAPP subunits by siRNA revealed an unexpected result: 
depletion of the TRAPPC12 subunit arrested cells in mitosis and this phenotype was not 
seen for any other TRAPP subunit depletion. 
 
The unexpected finding of the involvement of TRAPPC12 in mitosis led to 
several questions that I will try to answer in this study. During mitosis many proteins are 
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exposed to posttranslational modification such as ubiquitination or phosphorylation. In 
this study, initially I will establish if TRAPPC12 is subjected to posttranslational 
modifications in order to switch its role from membrane trafficking to mitosis, and then 
determine the timing of this modification. Afterwards, I will investigate which residues of 
TRAPPC12 are responsible for its involvement in mitosis and which one of them has the 
more adverse effect when mutated. 
 
Until now we know that TRAPPC12 is a subunit of TRAPP III complex and is 
likely to be involved in anterograde traffic between the ER and the Golgi (Scrivens et al., 
2011) and possibly in autophagy (Behrends et al., 2010). My present study and recent 
data from our laboratory suggest it also moonlights as a mitotic protein. 
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  2.1. Buffers and solutions 
All buffers and solutions used in this study are listed in Table 2.1 at the end of 
this Materials and Methods section. 
 
  2.2 Molecular biology techniques 
All oligonucleotides, plasmids and DNA constructs generated in this study are 
listed in Table 2.2 at the end of this Materials and Methods section. 
 
2.2.1 Preparation of DNA and measuring DNA concentration 
Plasmid DNA was extracted using a Bio Basic miniprep kit following the 
instructions supplied by the manufacturer. To measure the concentration, DNA was 
diluted 100 fold in dH2O and 500 µl was added to a quartz micro-cuvette. The 
absorbance was measured using an Ultrospec 2100pro Spectrophotometer at 
wavelengths of 260 and 280 nm. 
 
2.2.2 Site Directed Mutagenesis with Stratagene Pfu Turbo 
Site-specific mutagenesis was used to create most of the TRAPPC12 mutants. 
The plasmid pDONOR-TRAPPC12siRNA-resistant was used as a template and the 
oligonucleotides are listed in Table 2.2. Site-specific mutagenesis was carried out using 
the QuikChange® XL Site-Directed Mutagenesis Kit (Stratagene) according to the 
manufacturer’s protocol with some changes listed below. Briefly, a typical mutagenesis 
reaction contained 33.5 µl ddH2O, 5 µl 10X Pfu Turbo Reaction mix, 2 µl 2.5 mM dNTP, 
2.5 µl DMSO, 2 µl Primer1 mix (final concentration of 0.4 µM), 2 µl Primer2 mix (final 0.4 
µM), 2 µl Template DNA (~200 ng), 1 µl Pfu turbo DNA Polymerase. The mixture was 
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subjected to the following protocol in a thermal cycler: 19 cycles of denaturation (95°C 
for 20 seconds), annealing (55°C for 30 seconds), elongation (68°C for 10 minutes), 
preceeded by an initial denaturation for 2 minutes. After this protocol, the sample was 
incubated with 1µl of DpnI overnight at 37°C. 5 µl of the DpnI-digested mixture was used 
for transformation into subcloning efficiency DH5α competent cells.  
 
2.2.3 Transformation of Bacteria 
Transformation of DNA constructs into DH5α competent cells (Invitrogen) or DM1 
cells (Invitrogen) was performed as follows. Cells were thawed on ice and 80 µl aliquots 
were mixed with the appropriate amount of DNA (either a recombination reaction or a 
ligation reaction) by gentle pipetting. Samples were incubated on ice for 30 minutes, 
heat shocked at 42°C for 1 minute and placed on ice for 5 minutes. After addition of 1 
mL of LB, the transformation mixture was incubated at 37°C for 1 hour at 220 rpm in a 
shaking incubator. Cells were pelleted at 2500 rpm for 2 minutes then resuspended in 
200 µl of LB broth and spread onto LB-agar plates containing ampicillin or kanamycin. 
Plates were incubated overnight at 37°C and analyzed the next morning. 
 
2.2.4 Plasmid preparation by Gateway® Cloning 
Gateway® cloning was used to insert the amplified gene of interest into the entry 
vector pDONR201 by a BP recombination reaction, and then transferred into the 
destination vector containing a V5 or FLAG-tag by an LR recombination reaction. All 
oligonucleotides used in this study are listed in Table 2.2. Briefly, the gene of interest 
was amplified by polymerase chain reaction (PCR) with oligonucleotides (Table 2.2) 
containing the attB1 and attB2 recombination sequences.  A 3.5 µl BP reaction, 
containing 45 ng entry vector pDONR201, 45 ng PCR product, 0.5 µl BP Clonase 
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Enzyme and TE pH 8.0, was set up and incubated at 25°C overnight. The entire reaction 
mix was transformed into 80 µl of subcloning efficiency DH5α competent cells as 
described above. The transformation was plated onto LB plates containing 100 µg/ml 
kanamycin.  Once a successful insertion into the entry vector was verified by restriction 
enzyme digestion and DNA sequence analysis, an LR recombination reaction was 
performed to transfer the gene of interest from the entry vector to a pcDNA3.1-based 
destination vector (untagged, FLAG-, V5- or YFP-tagged). Briefly a 3.5 µl reaction, 
containing 45 ng destination vector, 45 ng entry clone, 0.5 µl LR Clonase Enzyme and 
TE pH 8.0 to was set up and incubated at 25°C overnight. The entire reaction was 
transformed into 80 µl of subcloning efficiency DH5α competent cells as above. The 
transformation was plated on LB plates containing 100 µg/ml ampicillin. The Amp-
resistant colonies were digested with the restriction enzyme BsrGI to verify successful 
recombination.  
 
2.2.5 Restriction enzyme digestion 
In some cases, restriction enzyme cloning was used. All restriction enzymes and 
their respective 10X buffers were obtained from New England Biolabs, USA. Restriction 
enzyme digestion was used to prepare or check DNA inserts for subcloning. To prepare 
DNA inserts, plasmid DNA was mixed with restriction enzyme, 10X buffer, and dH2O. All 
the reactions were incubated at 37°C for 1 hour. Bovine serum albumin (BSA) (1 µl of 10 






2.2.6 Agarose gel Electrophoresis 
Analysis of DNA was performed on agarose gels prepared with 70ml of TBE with 
1% w/v agarose and ethidium bromide (final concentration of 0.5 µg/ml). 6X DNA loading 
solution was added to the samples at a final concentration of 1X prior to loading in the 
gel. Gel electrophoresis was performed in 1X TBE at 100V. DNA was visualized by 
exposure to UV light. 
 
2.2.7 Gel extraction of DNA 
In order to purify DNA either generated by PCR or following digestion with 
restriction enzymes, samples were first resolved by agarose gel electrophoresis. The 
DNA of interest was excised and then purified using Bio Basic Gel extraction kit as per 
the manufacture’s instructions. 
 
2.2.8 Ligation 
The T4 DNA ligase (400 units/µl) and 10X buffer used in all ligation reactions was 
obtained from New England Biolabs, USA. Insert and vector were mixed at a 3:1 molar 
ratio, together with 10X buffer, 200 Units T4 DNA ligase and dH2O. The mixture was 
then incubated at room temperature overnight before transformation into competent 
bacteria. 
 
  2.3 Tissue culture techniques 
A list of all small interfering RNAs (siRNA) and plasmids used in this study are 





2.3.1 Tissue culture media and solutions 
All tissue culture reagents were presterilised, stored at 4°C and pre-warmed to 
37°C unless otherwise specified. Cell lines were maintained in Dulbecco’s Modified 
Eagle’s Medium (DMEM) supplemented with 2 mM L-glutamine. Before use, all media 
were supplemented with 10% fetal bovine serum (FBS) (Wisent) unless otherwise 
stated.  
 
2.3.2 Maintenance of cell cultures 
Cells were grown in a humidified incubator with 5% carbon dioxide at 37°C. Cell 
lines were maintained in DMEM. To subculture cells, medium was removed when cells 
reached confluence, and the cells were washed twice in PBS. 3 ml of 0.05 % Trypsin 
solution was added to the cells, which were then incubated at 37°C for 2-3 minutes. The 
trypsin was carefully removed without disturbing adherent cells, after which cells were 
detached with media containing FBS. The re-suspended cells in DMEM were re-plated 
to the required density.  
 
2.3.3 Cryopreservation of cells 
Cells were trypsinised and pelleted by centrifugation at 1900 rpm for 2 minutes. 
Each confluent plate was divided into 4-5 aliquots and each aliquot re-suspended in 1ml 
of cold DMEM-FBS with 10% v/v dimethyl-sulphoxide (DMSO). The cells were stored in 
sterile ampoules, and placed in freezing boxes at −80°C over night, allowing cooling at a 
controlled rate of ~1°C/minute. The ampoules were then transferred to a liquid nitrogen 
storage tank. To recover cells from liquid nitrogen, cell suspensions were thawed quickly 
in a 37°C water-bath followed by immediate drop-wise transfer to a plate containing 10ml 
of DMEM-FBS media. The cells were then incubated at 37°C. 
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2.3.4 Cell synchronization 
Various techniques were performed to synchronize HeLa cells in different stages 
of the cell cycle:  
Double thymidine block to arrest cells at the G1/S boundary: cells were treated with 2 
mM thymidine (Sigma) for 18 hours, washed 2 times in PBS and released in DMEM for 6 
hours, treated a second time with 2 mM thymidine for 16 hours, washed 2 times in PBS 
and released in DMEM for the times indicated in the Results section.  
Colcemid treatment to arrest cells in prometaphase: cells were treated with 5 µg/mL 
Colcemid (Gibco KaryoMAX) for 18 hours, collected with shake off, washed 2 times in 
PBS and either released into DMEM or immediately harvested.  
Nocodazole treatment to arrest cells in prometaphase: cells were treated with 100 ng/ml 
Nocodazole (Sigma) for 18 hours, washed 2 times in PBS and released into DMEM, or 
in some cases, after a double thymidine treatment cells were released into DMEM media 
for 3 hours and then 100 ng/ml Nocodazol was added before harvesting at different time 
points. Cell lysates were then analyzed by Western blotting. 
 
2.3.5 DNA and siRNA transfection of mammalian cells using JetPRIME 
At the time of transfection cells were 60% confluent. The transfection was 
performed using JetPRIME (Polyplus) as per the manufacture’s instructions. Briefly, for a 
single well of a 6-well plate, 1µg DNA or 10 nM siRNA was diluted into 200 µl of 
JetPRIME buffer followed by the addition of 4 µl JetPRIME reagent. After vortexing for 
10 seconds and a brief centrifugation in a microcentrifuge the transfection mix was 
incubated for 20 min at RT. The transfection mix was then added drop-wise to the cells 
in regular cell growth medium and the cells were returned to the incubator. The medium 
was replaced 24 hours after transfection. 
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2.4. Protein chemistry techniques  
A list of all antibodies used in this study is listed in Tables 2.4 at the end of this 
Materials and Methods section. 
2.4.1 Protein concentration by Bradford assay  
A small volume (1-10 µl) of the protein sample was carefully diluted and mixed 
with 1 ml of Bradford reagent (BioRad). The absorbance was measured in an Ultrospec 
2100pro spectrophotometer at 595 nm against 1ml of Bradford reagent blank. Protein 
concentrations were determined by comparison with a standard calibration curve 
prepared from known quantities of BSA (0-10 µg). 
 
2.4.2 Sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-
PAGE) and Western blotting 
For analysis by Western blotting, cells were harvested with lysis buffer then 
diluted with 4X SDS sample buffer. 5 – 40 µg of whole cell lysates were electrophoresed 
on 8% (>50kDa) or 15% (< 50kDa) polyacrylamide gels. The samples were typically 
electrophoresed at 120V in running buffer. Proteins resolved by SDS polyacrylamide gel 
electrophoresis (SDS-PAGE) were transferred to nitrocellulose membranes using 
standard procedures (Sambrook & Russell, 2001) at 30 V overnight. After blocking with 
5 % (w/v) skim milk powder or 5 % BSA (bovine serum albumin), membranes were 
incubated for 2 hours with primary antibodies (Table 2.4) in PBSt. After 2 washes for 5 
minutes each, membranes were incubated for 1 h at room temperature with peroxidase-
labeled goat anti-mouse/rabbit IgG (Kirkegaard & Perry Laboratory) secondary antibody 
at a dilution 1:10000 and then the antigen-antibody complex was visualized using the 
enhanced chemiluminescence (ECL) detection reagent (Amersham Life Science, 
Buckinghamshire, England), following the protocols provided by the manufacturer. 
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2.4.3 Lambda phosphatase treatment 
Cells were lysed in lysis buffer and centrifuged at 16,000 rpm for 15 minutes at 
4°C. Total cell extracts were incubated with Lambda phosphatase solution (New 
England Biolabs, Inc.) containing 400 units of Lambda phosphatase (λPPase), 1x 
λPPase buffer and 2 mM MnCl2. The reaction mixture was incubated for 2 hours at 
30°C. The reaction was terminated by the addition of 4 X SDS-sample buffer. The 
samples were boiled at 100°C for 2 minutes before SDS-PAGE and western blotting 
analysis. 
 
2.4.4 Gel Filtration chromatography 
For gel filtration experiments, HeLa cells were lysed with Lysis buffer. Using the 
GE ÄKTA FPLC chromatography system, 5 mg of total cell extract was loaded onto a 
Superose 6 preparation grade column (GE Healthcare) at a flow rate of 0.5 ml/min. The 
column was pre-equilibrated with 2 volumes of gel filtration buffer. Fractions of 0.5 ml 
were collected and resolved by SDS-PAGE and western blotting analysis. 
 
2.5 Microscopy 
Images were captured with a Nikon Eclipse TS1000 Epi-Fluorescence 
microscope using a 20X objective lenses (ELWD 20X/0.45), and then ImageJ was used 









Table 2.1. Buffers and solutions used in this study 
 
Reagent name Components 
Ampicillin 100 mg/mL in dH2O 
dNTP solution 
(10x) 
2 mM each of dATP, dCTP, dGTP and dTTP 
DNA loading 
solution 6X 
 30%v/v of glycerol, 0.25% w/v of bromophenol blue in dH2O 
Gel filtration 
buffer 
50mMTris pH7.2, 150mM NaCl, 0.5mM EDTA, 1mM DTT 
Kanamycin 100 mg/mL in dH2O 
Luria Broth (LB) 1% w/v tryptone, 0.5% w/v yeast extracts, 1% w/v NaCl 
LB-agar plates LB with 1.5% agar 
Mammalian lysis 
buffer 
50mMTris pH7.2, 150mM NaCl, 0.5mM EDTA, 1mM DTT, 1% Triton X-
100(v/v), 1 tablet of protease inhibitor cocktail (Roche) and 2 tablets of 
Phospho-Stop (Roche) per 10mL. 
PBS 0.8% w/v NaCl, 0.02% w/v KCl, 0.061% w/v Na2HPO4, 0.02% w/v KH2PO4, 
pH 7.3 
PBSt PBS with 0.1% Tween-20 (v/v) 
SDS-PAGE 
running buffer 
25mM Tris-base, 200mM glycine, 0.1% SDS 
4XSDS sample 
buffer 
80 mM Tris-HCl (pH 6.8), 2% w/v SDS, 10% v/v glycerol, 0.1% 
bromophenol blue, 5% v/v β-mercaptoethanol 
TBE 100mM Tris, 100mM boric Acid, 2mM EDTA, pH 8.3 
TE 10 mM Tris, pH 8.0 , 1 mM EDTA 
Western blotting 
transfer buffer 












Table 2.2 List of Oligonucleotides and the constructs that were generated in this study. 
 
 



























C12T107A-F GCCCGGAGCCCGCGGGCGCCCCGAGTCCCAGCGGCGAGGCCGACGG C12 T107A 
C12T107A-R CCGTCGGCCTCGCCGCTGGGACTCGGGGCGCCCGCGGGCTCCGGGCC  
C12S109A-F GGCCCGGAGCCCGCGGGCACCCCGGCTCCCAGCGGCGAGGCCGACGG C12 S109A 
C12S109A-R CCGTCGGCCTCGCCGCTGGGAGCCGGGGTGCCCGCGGGCTCCGGGCC  
C12S127A-F GAGGACGCGGCACCCAGTGCCGGAGGGGCCCCGAGGCAGG C12 S127A 
C12S127A-R CCTGCCTCGGGGCCCCTCCGGCACTGGGTGCCGCGTCCTC  
C12S182A-F CGAGCCGCAGATGGTGAAGGCGCCCAGCTTCGGTGGCGCCAGCG C12 S182A 
C12S182A-R GCTGGCGCCACCGAAGCTGGGCGCCTTCACCATCTGCGGCTCG  
C12S184A-F GAGCCGCAGATGGTGAAGTCGCCCGCCTTCGGTGGCGCCAGCG C12 184A 
C12S184A-R CGCTGGCGCCACCGAAGGCGGGCGACTTCACCATCTGCGGCTCG  
107/109-DD-F CGGAGCCCGCGGGCGACCCGGATCCCAGCGGCGAGGC C12 
TS107/109DD 
107/109-DD-R GCCTCGCCGCTGGGATCCGGGTCGCCCGCGGGCTCCG  
109-D-F CGGAGCCCGCGGGCACCCCGGATCCCAGCGGCGAGGC C12 S109D 
109-D-R GCCTCGCCGCTGGGATCCGGGGTGCCCGCGGGCTCCG  
107-D-F CGGAGCCCGCGGGCGACCCGAGTCCCAGCGGCGAGGC C12 T107D 





























Table 2.3 List of siRNA’s used in this study 
 
Targeting gene Code Sequence (5’ to 3’) 
Mad2L1HSS106245 7643164 (Invitrogen) GGGAAGAGUCGGGACCACAGUUUAU 
TRAPPC2 s12673 (Ambion) CAAUUCUCCUAUUCGAUCAtt 
TRAPPC2L s28534(Ambion) AGCCCUUCGAGACAACGAAtt 
TRAPPC4 s28090(Ambion) CGAAAGAUUUAUGAGAUUUtt 
TRAPPC8 s22569(Ambion) CAGCUCUCCUAAUACGGUUtt 
TRAPPC9 s38117(Ambion) GGAGAAAGUCAGCAACUAAtt 
TRAPPC10 (Cedar Lane) GUGCCAACUGGCUgacttttt 
TRAPPC11 s226950 (Ambion) GGAUUUAUAAACUACAAGAtt 
TTC15 s27465 (Ambion) CGGACAAGCUGAACGAACAtt 











Antigen Host Code Source Dilution 
Cyclin B1 Rabbit 4138P Cell Signaling Technology  1:1000 
Flag Mouse M2 Sigma  1:10000 
Histone H3 (phosphor-S10) Rabbit 3377P Signaling Technology  1:1000 
TTC15 Mouse Ab88751 Abcam 1:1000 
Tubulin Mouse Ab27076 Abcam 1:5000 





3.1. Depletion of TRAPPC12 leads to a mitotic arrest 	  
In order to investigate the role of each subunit of the mammalian TRAPP 
complex in membrane trafficking, small interfering RNA (siRNA) knockdown was used to 
deplete HeLa cells of individual proteins. Depletion of the TRAPPC12 subunit, but no 
other tested TRAPP subunit, showed an increase in the number of round cells that is a 
hallmark of a cell in mitosis (Figure 3.1). Upon closer investigation by brightfield 
microscopy it is clear that the majority of the TRAPPC12-depleted cells were arrested in 
metaphase with a noticeable formation of a metaphase plate (not shown). This 
phenotype has a striking similarity with the depletion of CENP-E from cells as seen in 
previous studies (McEwen et al., 2001; Yao et al., 2000). Depletion of CENP-E results in 
a failure in metaphase chromosome alignment due to defects in kinetochore-microtubule 
attachment (Mcewen et al., 2001; Schaar et al., 1997; Yao et al., 2000). Quantification of 
different fields from different knockdown experiments revealed an increase of the mean 
mitotic index for the TRAPPC12-depleated cells (29.7%±2.3) compared to cells treated 
with a non-specific RNA (6.4%±0.43) (Figure 3.1B). This unexpected finding suggests 










Figure 3.1. Depletion of TRAPPC12 results in a mitotic arrest. A) HeLa cells were 
photographed by brightfield microscopy at 20X magnification 24 hours after treatment with siRNA 
against the TRAPP subunits indicated. B) Cells were quantitated by counting the number of 
mitotic cells in multiple fields over three independed experiments. Error bars indicate standard 
deviation. Note that for simplicity “Trapp” is omitted for each subunit, si – small interference RNA, 
NS – non-specific siRNA. 
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3.2 Bioinformatics analysis of TRAPPC12 
 
Solving the structure of a protein is an important step toward determining its 
function. In the absence of a crystal structure, bioinformatic analysis can provide limited 
information on the protein of interest. BLAST search of TRAPPC12 (NP_057114.5) 
shows a conserved region of tetratricopeptide repeat (TPR) motifs. TPR motifs are 
important for protein-protein interactions and are commonly found in cell cycle proteins. 
These motifs are very diverse with a degenerate sequence of ~34 amino acids but their 
structure remains conserved. Due to their structure, TPR domains act as ligand binding 
domains and the proteins that contain them usually support multiprotein complex 
formation (Scheufler et al. 2000).  
 
For further exploration of this conserved region of TRAPPC12, KEGG database 
was used. The database resource KEGG (Kyoto Encyclopedia of Genes and Genomes) 
contains information on proteins and their conserved motifs. Based upon this database, 
the sequence of TRAPPC12 aligns to varying degrees with different TPR motifs 
including a match for the anaphase-promoting complex (APC) domain (Figure 3.2A). 
Anaphase-promoting complex (APC) is an E3 ligase that is involved in mitosis by 
mediating the degradation of securin and cyclin B1 (Glotzer et al., 1991). It should be 
noted that the Expect (E) -value for the APC domain is very high, suggesting that the 
alignment may be by chance (Table 3.1). KEGG results show the presence of 16 
potential TPR motifs in TRAPPC12. Since some of them have a high E-value, and APC 
also contains TPR motifs, this further suggests that the alignment with APC3 maybe by 
chance (Table 3.1). However, given the role of TRAPPC12 in mitosis this alignment is of 
potential interest. Based on both KEGG analysis and analysis of the TPR prediction 
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software TPRpred that are used to detect TPR domains and compute the statistical 
significance of their occurrence, TRAPPC12 likely contains 4 TPR motifs.  
 
In order to analyze the conservation of the TPR motifs in TRAPPC12 among 
species, the Treefam database was used to generate a phylogenetic tree. The resulting 
phylogenic tree shows that the TPR domains are conserved in this protein throughout 
different species (Figure 3.2B). However, differences have occurred in the evolutionary 
line demonstrated by the absence of TPR motifs in C.elegans (Figure 3.2B). The 
absence of a TPR domain in C. elegans and other worms suggests that the repeat may 
have been expanded independently in these organisms or that the TPR motif was not 
detected by the program due to diverse and degenerate nature of these motifs.  
 
The Phyre 2 database was then used to predict the tertiary structure of 
TRAPPC12. The result showed that TRAPPC12 is composed of 44% alpha helices, 
mostly at the C-terminus, and 53% is unstructured, mostly at the N-terminus.  Based on 
the resolved structures of the similar domains that match the TPR and other known 
domains at the C-terminus of the protein, the program was able to elucidate a structure 
for TRAPPC12 (Figure 3.2C). The predicted structure of TRAPPC12 shows that the TPR 
domain (Figure 3.2C, blue) is exposed on the outside of the protein suggesting an easy 
way to facilitate protein-protein interaction. Furthermore, the presence of the 
unstructured region at the N-terminus (Figure 3.2C, pink) is noteworthy for several 
reasons. First, unstructured regions have been shown to facilitate bindings that are 
controlled by post translational modification. This is commonly seen in proteins involved 
in cell signalling and chromatin remodelling (Collins et al., 2008; Iakoucheva et al., 2002; 
Sandhu, 2009). Second, as will be described in detail, it is this region of TRAPPC12 that 
is phosphorylated during mitosis (see section 3.3). Overall, the results of the 
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bioinformatic analysis can help in the prediction of key areas that through mutations can 
reveal some function of TRAPPC12. 
 
 
Motif	  id	   From	   To	   Definition	   E-­‐value	  
TPR_1	   547	   577	   Tetratricopeptide	  repeat	   0.0016	  
TPR_2	   547	   577	   Tetratricopeptide	  repeat	   0.14	  
TPR_2	   623	   653	   Tetratricopeptide	  repeat	   0.0065	  
TPR_2	   656	   687	   Tetratricopeptide	  repeat	   0.21	  
TPR_6	   547	   577	  
	  
0.0058	  
TPR_11	   549	   604	  
	  
9.90E-­‐05	  
TPR_11	   626	   685	  
	  
4.40E-­‐08	  
TPR_12	   545	   609	  
	  
0.0011	  
TPR_12	   581	   650	  
	  
0.015	  
TPR_12	   622	   687	  
	  
0.23	  
TPR_14	   627	   661	  
	  
0.75	  
TPR_16	   555	   605	  
	  
0.23	  
TPR_16	   627	   686	  
	  
2.50E-­‐05	  
TPR_17	   643	   673	  
	  
0.094	  
TPR_19	   555	   612	  
	  
0.3	  
TPR_19	   631	   690	  
	  
3.90E-­‐06	  
Apc_3	   547	   604	   APC,	  subunit	  3	   0.096	  
Apc_3	   595	   678	   APC,	  subunit	  3	   0.33	  
Coatomer_E	   617	   691	   Coatomer	  epsilon	  subunit	   0.00061	  
 













Figure 3.2. Structural analysis of TRAPPC12. A) TPR Motifs extracted from the KEGG analysis 
found in TRAPPC12. The database resource KEGG (Kyoto Encyclopedia of Genes and 
Genomes) of TRAPPC12 (ID number hsa: 51112) shows different TPR domains and the 
presence of the anaphase-promoting complex APC3 domain. http://www.kegg.jp/ssdb-
bin/ssdb_motif?kid=hsa:51112                             
B) The TreeFam family. The sequences were aligned using MCoffee. TreeBest (Ruan et al 2008) 
was used to build a gene tree and reconcile it with the species tree. TreeBest built 5 source trees 
(Guindon et al 2010), and then merged them into one tree trying to minimize the number of 
duplications using a species tree. Legend: pink and blue rectangles signify the TPR domains in 
the sequences. http://www.treefam.org   
C) Tertiary structure of TRAPPC12 predicted by the Phyre2 program. The amino-terminus is 




3.3. TRAPPC12 is hyperphosphorylated during mitosis 	  
The increase in mean mitotic index (see section 3.1) from the siRNA knockdown 
experiment led to further investigation of the role of TRAPPC12 during mitosis. Western 
blot analysis of the cells arrested in prometaphase with the use of a drug called colcemid 
showed that TRAPPC12 migration on a polyacrylamide gel was retarded (Figure 3.3A). 
The colcemid-induced arrest in mitosis is indicated by the appearance of the 
phosphorylated histone H3 that is present only during mitosis (Figure 3.3A) (Hendzel et 
al., 1997). A reduction in electrophoretic mobility is often an indication of phosphorylation 
of a protein and many proteins that function during mitosis are subjected to this type of 
posttranslational modification. To test if this was occurring to TRAPPC12, lysates from 
asynchronous cells, cells arrested at the G1/S boundary by thymidine treatment and 
cells arrested in prometaphase using colcemid were treated with lambda protein 
phosphatase. Lambda protein phosphatase has an activity towards phosphorylated 
serine, threonine and tyrosine residues. The Western blot analysis showed that the 
reduced mobility of TRAPPC12 was reversed by lambda phosphatase treatment of 
colcemid -treated cells indicating that this protein is hyperphosphorylated during mitosis 
(Figure 3.3B). Interestingly, arrested cells at the G1/S boundary also showed to be 
dephosphorylated to a lesser extent by lambda phosphatase indicating that TRAPPC12 
















Figure 3.3. TRAPPC12 is hyperphosphorylated during mitosis. A) Lysates were prepared 
from HeLa cells that were untreated or treated with colcemid to arrest the cells in prometaphase 
(Colc) and subjected to western analysis. Tubulin was used as a loading control and phospho-
histone H3 (p-Hist-H3) was used as a mitotic marker. B) Lysates were prepared from HeLa cells 
that were untreated (Async), treated with thymidine to arrest the cells at the G1/S boundary 
(Thym), or treated with colcemid to arrest the cells in prometaphase (Colc). A portion of each 
lysate was left untreated (-) or treated with lambda phosphatase (λ-PPase) (+) prior to western 
analysis. Tubulin was used as a loading control and phospho-histone H3 (p-Hist-H3) was used as 





3.4. TRAPPC12 is transiently phosphorylated during mitosis 	  
After establishing that TRAPPC12 is phosphorylated during mitosis, the question 
addressed was the timing of the mitotic phosphorylation and to determine when 
dephosphorylation occurs. To answer this, time course experiments were conducted as 
follows. HeLa cells were treated with thymidine to synchronize the cells at the G1/S 
boundary and then released into medium containing nocodazole to trap the cells in 
mitosis. Cell lysates were collected at different time points after treatment with 
nocodazole and subjected to western blot analysis. At approximately 11 hours after 
release from the G1/S boundary, TRAPPC12 showed signs of phosphorylation indicated 
by the appearance of the higher molecular weight form of the protein (Figure 3.4A). 
Molecular markers like cyclinB1 and phospho-histone H3 were used to determine at 
what time the phosphorylation of TRAPPC12 occurs. CyclinB1 is present at low 
concentrations at G1/S phase but its levels start increasing during prophase reaching its 
peak at metaphase (Jackman et al., 2003). Histone 3 phosphorylation initiates during 
late G2 and continues until anaphase when its dephosphorylation starts (Hendzel et al., 
1997). Based on these molecular markers the phosphorylated form of TRAPPC12 
appears as the cells enter mitosis. To determine when the dephosphorylation of 
TRAPPC12 occurs, HeLa cells were treated with nocodazole for 18 hours to block the 
cells in mitosis and then mitosis was allowed to progress by releasing the cells into 
regular medium without nocodazole. Cell lysates were collected at different time points 
after release and subjected to western blot analysis. The disappearance of the 
phosphorylated form of TRAPPC12 occurs at approximately 4 hours after release 
(Figure 3.4B). This coincides with the degradation of cyclinB1, which occurs during 
anaphase (Figure 3.4B). Collectively, this data suggests that the phosphorylation of 







Figure 3.4. Transient phosphorylation of TRAPPC12 during mitosis. A) HeLa cells were 
arrested at the G1/S boundary by treatment with thymidine. A sample was removed (0 hours) and 
then the cells were transferred to growth medium containing nocodazole (see Materials and 
methods) at which point samples were removed at the times indicated (hours). B) HeLa cells 
were arrested in prometaphase by treatment with nocodazole. A sample was removed (0 hours) 
and then the cells were transferred to regular growth medium at which point samples were 
removed at the times indicated (hours). The cells were lysed and examined by western analysis 
for the proteins indicated. Tubulin was used as a loading control and phospho-histone H3 (p-Hist-





3.5. Phosphorylated residues of TRAPPC12 that may be involved in 
mitosis. 
 
In order to determine which residues in TRAPPC12 are phosphorylated during 
mitosis, a combination of mass spectrometry, bioinformatics predictions and previously 
published phosphoproteomic analyses was used (Dephoure et al., 2008; Kettenbach et 
al., 2011; Mayya et al., 2009). The combined approach led to the examination of 5 
potential residues: T107, S109, S127, S182 and S184. Using site directed mutagenesis, 
11 mutants were generated that contained one or two of these sites changed to either 
non-phosphorylatable alanine (A) residues or phosphomimetic aspartic acid (D) residues 
(Figure 3.5A). The mutants were made siRNA-resistant to prevent degradation when 
treated with siRNA to TRAPPC12. This allowed for expression of the mutants in cells 
where the endogenous protein was depleted. In order to detect the exogenous proteins 
they were tagged with a V5 epitope. The ability of these mutants, compared to wild type 
TRAPPC12, to rescue the TRAPPC12 depletion-induced increase in the mitotic index 
was then assessed (Figure 3.5B). All of the mutants containing one or two residues 
changed to alanine or aspartic acid were able to suppress the mitotic index phenotype of 
TRAPPC12-depleted cells. Some of these results are quantitated in Figure 3.5C. This 
led to the conclusion that more than two residues are responsible for the involvement of 








Figure 3.5. Phosphorylated residues of TRAPPC12 that may have a role during mitosis. A) 
Schematic representation of the different phosphorylation sites of TRAPPC12. The 5 potential 
residues, T107, S109, S127, S182 and S184 were changed singly or as pairs as indicated in the 
figure, to either non-phosphorylatable alanine residues (A) or phosphomimetic aspartic acid 
residues (D) and made siRNA-resistant. B) HeLa cells were photographed by brightfield 
microscopy at 20X magnification 24 hours after transfection with the mutants and/or treatment 
with siRNA against TRAPPC12 as indicated. C) Cells were quantitated by counting the number of 
mitotic cells in multiple fields over three independent experiments for some of the conditions. si – 
small interference RNA.  
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3.6. Reversible phosphorylation of TRAPPC12 is critical for its mitotic 
function 
 
The results above suggested that more than two residues are involved in the 
mitotic function of TRAPPC12. Therefore, mutants that contained all five potential 
residues changed to either non-phosphorylatable alanine (5A) residues or 
phosphomimetic aspartic acid (5D) residues were constructed (Figure 3.6A). As shown 
in Figure 3.6B, although wild type TRAPPC12 as well as TRAPPC12-5A could suppress 
the mitotic index phenotype of a TRAPPC12 depletion nearly equally, TRAPPC12-5D 
showed a reduced ability to suppress this phenotype. Quantitation of the mitotic index 
confirmed that the TRAPPC12-depleted phenotype could be suppressed with expression 
of the wild type and TRAPPC12-5A mutant but only partially by the TRAPPC12-5D 
mutant (11.9%±0.02 for wild type, 9.8%±0.05 for 5A and 20.0%±0.08 for 5D) (Figure 
3.6C). These results suggest that, although phosphorylation of TRAPPC12 is not 
necessary (based on the TRAPPC12-5A mutant), phosphorylation needs to be 





















Figure 3.6. Reversible phosphorylation of TRAPPC12 is critical for its mitotic function. A) 
Schematic representation of two constructs where 5 potential residues ( T107, S109, S127, S182 
and S184) were changed to either non-phosphorylatable alanine residues (5A) or 
phosphomimetic aspartic acid residues (5D) and made siRNA-resistant. B) HeLa cells were 
photographed by brightfield microscopy at 20X magnification 24 hours after treatment with siRNA 
against the TRAPPC12 or non-secific siRNA (NS). In some case, the cells were co-transfected 
with siRNA-resistant TRAPPC12 WT (wild type), siRNA-resistant TRAPPC12 5A or siRNA-
resistant TRAPPC12 5D mutants. Note that for simplicity “Trapp” is omitted. C) Cells from panel B 
were quantitated by counting the number of mitotic cells in multiple fields over three independent 














3.7. Role of TPR domain in the mitotic function of TRAPPC12 	  
After determining that the mitotically phosphorylated sites of TRAPPC12 reside in 
the unstructured regions of the amino-terminus of the protein (see Section 3.6), the next 
step was to determine the role of the TPR domain of this protein. TPR motifs are 
important for protein-protein interactions and are commonly found in cell cycle proteins. 
TRAPPC12 contains several such domains at the carboxyl-terminus (see Section 3.2). 
Using site directed mutagenesis, two constructs were established. One of the constructs 
lacked the TPR domain of TRAPPC12 and was made siRNA resistant since this 
oligonucleotide targets the amino-terminus of the protein (Figure 3.7, TRAPPC12-
NoTPR). The other construct lacked the amino-terminus (Figure 3.7, TRAPPC12-C-
term). To test the ability of these two mutants to suppress the TRAPPC12-depleted 
mitotic index phenotype, HeLa cells were transfected with TRAPPC12-NoTPR and C-
term constructs. As seen in Figure 3.7B and C, none of the mutants could suppress the 
TRAPPC12-depleted phenotype.  These results suggest that, the N-terminus of 
TRAPPC12 is necessary but not sufficient to rescue the mitotic phenotype and the TPR 
domain may play an important role for this protein either by facilitating interactions with 




Figure 3.7 Role of the TPR domain in the function of TRAPPC12.  A) Schematic 
representation of two constructs where the TPR domain was removed from the protein (No TPR) 
or where the TPR domain was expressed alone with a small portion of the protein (C-term). B) 
HeLa cells were photographed by brightfield microscopy at 20X magnification 24 hours after 
treatment with siRNA against TRAPPC12 or non-specific siRNA (NS). Cells were co-transfected 
with siRNA-resistant TRAPPC12 NoTPR or  TRAPPC12 (C-term). Note that for simplicity “Trapp” 
is omitted. C) Cells from panel B were quantitated by counting the number of mitotic cells in 
multiple fields over three independent experiments. Error bars indicate standard deviation.  
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3.8. Size exclusion chromatography of TRAPPC12 mutants 	  
As demonstrated above (Figure 3.1), it is clear that TRAPPC12 is the only 
component of TRAPP that also functions during mitosis, suggesting that it may be 
released from the TRAPP complex during this stage of the cell cycle. To examine this, 
lysates from both asynchronous and colcemid-treated cells were fractionated on a size 
exclusion column and the molecular size distribution of TRAPPC12 was assessed by 
western analysis. As seen in Figure 3.8  (top panel) TRAPPC12 from untreated cells 
displayed a broad size distribution (fractions 19-25) with the larger molecular size 
fractions corresponding to the TRAPP complex (Bassik et al., 2013). In contrast, 
TRAPPC12 from colcemid- treated cells displayed a shift to a smaller molecular size 
(second panel), peaking in fractions 24/25, suggesting that TRAPPC12 separates and is 
no longer part of the TRAPP complex during mitosis. In addition, the presence of a 
slower migrating band is visible in untreated cells and this band is only seen in fractions 
24/25. These are the same fractions where the mitotic form of TRAPPC12 fractionates, 
suggesting that during mitosis the hyperphosphorylated form of this protein is not found 
in the TRAPP complex. HeLa cells were transfected with TRAPPC12-5D or -5A mutants 
and then treated with colcemid to arrest the cells in prometaphase. Lysates from these 
cells were fractionated on a size exclusion column and were assed by western blot 
analysis. The slower migrating band is seen to be present in smaller molecular size of 
the overexpressed wild type TRAPPC12 and the 5D mutant (third and fifth panel) but not 
in the 5A mutant (fourth panel) in colcemid-treated cells. Due to overexpression of the 
protein, no shift in molecular size was detected for the mutants of TRAPPC12 treated 
with colcemid. Overall, these results suggest that the hyperphosphorylated form of 
TRAPPC12 shifts at smaller molecular size fractions indicating dissociation from the 







Figure 3.8. Size exclusion chromatography of TRAPPC12-5A and -5D mutants. HeLa cells 
were left untransfected (top two panels) or transfected with either V5-tagged TRAPPC12 (third 
panel), TRAPPC12-5A (fourth panel) or TRAPPC12-5D (fifth panel). Some were treated with 
colcemid (Colc) overnight as indicated. Lysates were fractionated on a Superose 6 size exclusion 
column and probed for the TRAPPC12 protein with antibodies against TRAPPC12 for the top two 
panels and with anti-V5 for the rest. The migration of molecular size standards is indicated above 





The mammalian TRAPP complex was shown to be involved in various vesicle 
trafficking pathways outside ER-to-Golgi transport in addition to tethering and guanine 
nucleotide-exchange (GEF) activity. Indeed, several subunits of mammalian TRAPP 
have been suggested to have other functions (Brunet and Sacher, 2014). For example, it 
has been shown that TRAPPC9 mediates the recruitment of essential components 
during ciliogenesis and the depletion of TRAPPC3, TRAPPC9, or TRAPPC10 damages 
primary ciliary membrane biogenesis by inhibiting Rabin8 recruitment to the centrosome 
(Westlake et al., 2011). The ASH (ASPM, SPD-2, Hydin) domains of TRAPPC10 and 
TRAPPC11 were implicated in microtubule organization and TRAPPC8 was shown to 
promote ciliogenesis (Schou et al., 2014). TRAPPC4 (also known as synbindin) was 
found in the spines of neural dendrites where it is thought that, in concert with other 
proteins, it recruits intracellular vesicles to postsynaptic sites (Ethell et al., 2000). 
Work in this study provides evidence to suggest that TRAPPC12, a component of the 
mammalian TRAPPIII complex, has a role in mitosis. Prior to this study, the only known 
phenotype of the knockdown of mammalian TRAPP components such as TRAPPC2, 
TRAPPC2L, TRAPPC8, TRAPPC11, TRAPPC12 and TRAPPC13 was perturbation of 
Golgi structure (Scrivens et al. 2009; Scrivens et al. 2011; Duarte, 2012 unpublished 
results).  
 
The observations presented in this study show that depletion of TRAPPC12 
arrests cells in a metaphase-like state with a noticeable formation of a metaphase plate, 
a phenotype not seen for any other TRAPP subunit examined. Depletion of TRAPPC12 
shows a considerable increase of the mean mitotic index. This phenotype, as well as 
other phenotypic features, have a striking similarity with the depletion of CENP-E from 
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cells (McEwen et al., 2001; Yao et al., 2000). Depletion of CENP-E results in a failure in 
metaphase chromosome alignment due to defects in kinetochore-microtubule 
attachment (Mcewen et al., 2001; Schaar et al., 1997; Yao et al., 2000). Hence, this 
unexpected finding suggests that TRAPPC12 may be involved in mitosis. 
TRAPPC12 is a recently characterized protein (Scrivens et al., 2011) that does not yet 
have a solved crystal structure. Solving the structure of a protein is an important step 
toward determining its function so in the absence of a crystal structure, bioinformatic 
approaches were used to provide some information on this protein. A BLAST search 
showed that TRAPPC12 contains a tetratricopeptide repeat (TPR) domain that is well 
characterized as a protein-protein interaction domain. Based on both KEGG database 
and the TPR prediction software TPRpred that are used to detect TPR domains and 
compute the statistical significance of their occurrence, TRAPPC12 likely contains 4 
TPR motifs. Conservation of TRAPPC12 across species was established by building a 
phylogenic tree of TRAPPC12 protein. The phylogenic tree of TRAPPC12 showed that 
the TPR domain is conserved in this protein throughout different animal species. 
However, the C.elegans does not contain a TPR motif in TRAPPC12 but the detection 
may have been missed due to the diversity of the TPR motifs. Also it may be possible 
that during evolution some eukaryotes with larger genomes tend to have an abundance 
of domain repeats that possibly aid in more advanced cellular processes. Moreover the 
absence of a TPR domain in C. elegans and other worms suggest that the repeat has 
been expanded independently in fruit fly and chordates. The predicted structure of 
TRAPPC12 shows that the TPR domain may be exposed on the outside of the protein 
suggesting an easy way to facilitate protein-protein interactions. This was further 
confirmed when the truncated TRAPPC12 protein missing the TPR domain could not 
function properly, as evidenced by its inability to suppress the TRAPPC12 knockdown-
induced increase in mitotic index. Furthermore, in the predicted structure of TRAPPC12 
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the N-terminus seems to be unstructured. These unstructured regions have been shown 
to facilitate bindings that are controlled by post translational modification (Collins et al., 
2008; Iakoucheva et al., 2002; Sandhu, 2009) . The importance of five potential 
phosphorylation sites that reside in the N-terminus of TRAPPC12 was shown through 
mutations to be responsible for impeding the function of the protein during mitosis. 
Taken together, this may suggest that the amino terminal domain may have mitotically-
regulated interactions with other proteins involved in mitosis or it may interact with the 
TPR domain, positioning it for a protein-protein interaction. 
 
This study shows that like many mitotic proteins, TRAPPC12 is 
hyperphosphorylated during mitosis and it needs to be dephosphorylated for cells to exit 
mitosis. Following phosphorylation shortly after entry of the cells into mitosis, 
TRAPPC12 dephosphorylation occurs in parallel with a dramatic decrease in cyclin B1 
levels. This would be consistent with TRAPPC12 being a substrate for the cyclin B1-
CDK1 complex. In further support of this notion, three of the phosphorylation sites that 
were examined in this study (T107, S109 and S182) conform to a CDK1-cyclin B1 
consensus sequence of S/T-P, but further investigation is needed to confirm this 
hypothesis. Since TRAPPC12 may be phosphorylated during interphase as shown by 
the lambda phosphatase assay, it is tempting to speculate that TRAPPC12 may 
dissociate from the TRAPP holocomplex by dephosphorylation, which would allow the 
protein to function in mitosis. The dissociation from the holocomplex may start during 
late G2 phase when the Golgi begins to fragment (Lucocq et al., 1987). During mitosis, 
the hyperphosphorylated TRAPPC12 does not seem to be part of the TRAPP complex 
as shown by the size exclusion chromatography experiments where the protein shifts to 
lower molecular size fractions. However, inconclusive results were seen with the 
TRAPPC12 mutants due to overexpression of the phosphomimetic (5D) and 
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unphosphorylatable (5A) mutants of TRAPPC12 where no shift in molecular size was 
detected following colcemid treatment. This suggests that for future experiments stable 
cell lines that express the TRAPPC12-5A and -5D mutants at normal cellular levels 
should be established.  
 
A number of facts suggest a strong link between TRAPPC12 and CENP-E during 
mitosis. The observations presented in this study show that depletion of TRAPPC12 
leads to a mitotic arrest which is similar to the phenotype of CENP-E depleted cells 
(McEwen et al., 2001; Wood et al., 1997; Yao et al., 2000). The TRAPPC12-5D mutant 
that mimics mitotic phosphorylation is unable to suppress the TRAPPC12-depleted 
phenotype, which indicates that TRAPPC12 must be dephosphorylated for the cell cycle 
to progress. Interestingly, mitotic hyperphosphorylation enhances the recruitment of 
CENP-E to the kinetochore (M. Milev, unpublished results). Moreover, depletion of 
TRAPPC12 affects the localization of a number of kinetochore proteins, with CENP-E 
being the most dramatically affected, resulting in chromosome congression defects that 
activate the SAC (M. Milev, unpublished results). 
 
Overall, the data in this study suggest that TRAPPC12 is a moonlighting protein 
functioning in two diverse processes. TRAPPC12 is a component of the mammalian 
TRAPPIII holocomplex during interphase and in mitosis it may be a component of the 
outer kinetochore. The role of phosphorylation and dephosphorylation of TRAPPC12 
needs further investigation. To understand the mechanism of how TRAPPC12 changes 
functions and how it aids in chromosome congression we first need to explore how it 
dissociates from the holocomplex and what kinases and phosphatases, if any, are 
involved in this process.  
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There have been a number of membrane trafficking proteins that have been 
found to have other functions. These moonlighting functions occur either in a distinct 
cellular location or during a different phase of the cell cycle (Royle, 2011). The Rab6A’ 
isoform is associated with the Golgi and trans-Golgi network (TGN) during interphase 
(Mallard et al., 2002) and it has been implicated in the inactivation of the SAC in mitosis 
(Miserey-Lenkei et al., 2006). ZW10, involved in trafficking between the ER and Golgi 
(Hirose et al., 2004), is also a kinetochore component (Kops et al., 2005). AP-2, an 
adaptor for clathrin mediated endocytosis (CME) (Brodsky et al., 2001), has been shown 
to interact with BubR1 (Cayrol et al., 2002) and its depletion from cells  results in a 
mitotic phenotype (Boucrot and Kirchhausen, 2007).  
 
To consider a protein as a moonlighting protein it should fulfill an important 
requirement; it should have one or more unrelated functions that are not due to 
alternative splicing or gene fusion (Jeffery, 1999). Convincingly demonstrating a 
moonlighting function is a challenge. Mitotic defects could arise not by the depletion of 
the protein by siRNA but, rather, as a consequence of altered membrane trafficking. For 
example, when a cell is depleted of a membrane trafficking protein over a typical 48-72 
hour knockdown period, the cell must pass through approximately 3 cell cycles with 
decreasing amounts of the that protein. Previous studies have shown that the 
knockdown of TRAPPC12 causes Golgi fragmentation (Scrivens et al., 2011). It is 
noteworthy that Golgi fragmentation seems to be required for the cells to enter mitosis, 
controlling the cell cycle progression as a “Golgi mitotic checkpoint” (Colanzi and Corda, 
2007). This may suggest that since TRAPPC12 knockdown causes Golgi fragmentation 
it may indirectly influence mitosis. We do not believe this to be the case for several 
reasons. First, the effect of the depletion is seen in less then 24 hours after siRNA 
treatment. Second, the TRAPPC12-5D phosphomimetic mutant is unable to suppress 
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the increase in mitotic index following TRAPPC12 depletion while the 
unphosphorylatable TRAPPC12-5A mutant can. Finally, other TRAPP subunits have 
been shown to cause Golgi fragmentation when depleted from the cell but only depletion 
of TRAPPC12 is able to cause a mitotic arrest. This suggests that merely fragmenting 
the Golgi prior to mitosis is not sufficient to induce a mitotic phenotype, and that 
TRAPPC12 is likely playing a direct role in mitosis.    
 
To mitigate the problems of secondary effects created by the depletion of a 
protein by siRNA, researchers use different approaches. One of the approaches is the 
use of small molecule inhibitors. Although they are ideal, there are only few available for 
membrane trafficking proteins. Another approach recently described as ‘knocksideways’ 
is very promising (Robinson et al., 2010). The knocksideways method allows proteins to 
function normally and then can be removed from their site of action by targeting them to 
the mitochondria in a rapamycin-dependent manner. This method is currently being 
tested in our laboratory to further explore the dual roles of TRAPPC12. 
 
A logical question that needs to be addressed following this study is: how does 
TRAPPC12 switch from one role to the other? One obvious mechanism is that mitotic 
phosphorylation of TRAPPC12 causes its release from the TRAPP complex. This 
mechanism is common and is seen in the regulation of GRASP65, a Golgi stacking 
factor whose mitotic phosphorylation is key for disassembly of the Golgi at mitotic entry 
(Preisinger et al., 2005; Wang et al., 2003). The number of membrane trafficking 
proteins that have a proposed mitotic moonlighting function is increasing and this has led 
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